Phase One Development of Rapid COVID-19 Point of Care Test Complete
Phase One Development of Rapid COVID-19 Point of Care Test Complete Pepex Biomedical has effectively concluded first stage development efforts including successfully demonstrating working chemistry and manufacturing functionality of its existing electrochemical biosensor. Atlanta, GA, February 11, 2021 --(PR.com)-- Pepex Biomedical, Inc. (the “Company”), a leading developer of enzymatic biosensor technology, has completed the initial development phase of its forthcoming suite of immunosensor testing products designed to accurately identify COVID-19 antigens and antibodies in under 15 mi...
Source: pr.com